Except for its metabolic function, the nuclear localization of TKT has been demonstrated to promote HCC through the activation of the epidermal growth factor receptor (EGFR) pathway in a non-metabolic manner [61]. The gene discussed is EGFR; the disease is hepatocellular carcinoma.